» Articles » PMID: 2783477

The Effect of Dietary Supplementation with N-3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear Cells

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1989 Feb 2
PMID 2783477
Citations 351
Authors
Affiliations
Soon will be listed here.
Abstract

We examined whether the synthesis of interleukin-1 or tumor necrosis factor, two cytokines with potent inflammatory activities, is influenced by dietary supplementation with n-3 fatty acids. Nine healthy volunteers added 18 g of fish-oil concentrate per day to their normal Western diet for six weeks. We used a radioimmunoassay to measure interleukin-1 (IL-1 beta and IL-1 alpha) and tumor necrosis factor produced in vitro by stimulated peripheral-blood mononuclear cells. With endotoxin as a stimulus, the synthesis of IL-1 beta was suppressed from 7.4 +/- 0.9 ng per milliliter at base line to 4.2 +/- 0.5 ng per milliliter after six weeks of supplementation (43 percent decrease; P = 0.048). Ten weeks after the end of n-3 supplementation, we observed a further decrease to 2.9 +/- 0.5 ng per milliliter (61 percent decrease; P = 0.005). The production of IL-1 alpha and tumor necrosis factor responded in a similar manner. Twenty weeks after the end of supplementation, the production of IL-1 beta, IL-1 alpha, and tumor necrosis factor had returned to the presupplement level. The decreased production of interleukin-1 and tumor necrosis factor was accompanied by a decreased ratio of arachidonic acid to eicosapentaenoic acid in the membrane phospholipids of mononuclear cells. We conclude that the synthesis of IL-1 beta, IL-1 alpha, and tumor necrosis factor can be suppressed by dietary supplementation with long-chain n-3 fatty acids. The reported antiinflammatory effect of these n-3 fatty acids may be mediated in part by their inhibitory effect on the production of interleukin-1 and tumor necrosis factor.

Citing Articles

Interplay of n-3 Polyunsaturated Fatty Acids, Intestinal Inflammation, and Gut Microbiota in Celiac Disease Pathogenesis.

Bascunan K, Araya M, Rodriguez J, Roncoroni L, Elli L, Alvarez J Nutrients. 2025; 17(4).

PMID: 40004950 PMC: 11858531. DOI: 10.3390/nu17040621.


Facing stress and inflammation: From the cell to the planet.

Cavaillon J, Chaudry I World J Exp Med. 2024; 14(4):96422.

PMID: 39713080 PMC: 11551703. DOI: 10.5493/wjem.v14.i4.96422.


Does the Ketogenic Diet Mediate Inflammation Markers in Obese and Overweight Adults? A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Rondanelli M, Gasparri C, Pirola M, Barrile G, Moroni A, Sajoux I Nutrients. 2024; 16(23).

PMID: 39683396 PMC: 11643700. DOI: 10.3390/nu16234002.


An Optimized Ex Vivo n-3 PUFA Supplementation Strategy for Primary Human Macrophages Shows That DHA Suppresses Prostaglandin E2 Formation.

Kirchhoff R, Kampschulte N, Rothweiler C, Rohwer N, Weylandt K, Schebb N Mol Nutr Food Res. 2024; 69(1):e202400716.

PMID: 39676434 PMC: 11704825. DOI: 10.1002/mnfr.202400716.


Plant resources for immunonutrients and immunomodulators to combat infectious respiratory viral diseases: a review.

Kota S, Nelapati A, Govada V 3 Biotech. 2024; 14(12):302.

PMID: 39554986 PMC: 11568085. DOI: 10.1007/s13205-024-04143-y.